CONTEXT: Loss-of-function mutations in the coding region of MKRN3, a maternally imprinted gene at chromosome 15q11.2, are a common cause of familial central precocious puberty (CPP). Whether MKRN3 alterations in regulatory regions can cause CPP has not been explored to date. We aimed to investigate potential pathogenic variants in the promoter region of MKRN3 in patients with idiopathic CPP. PATIENTS/ METHODS: A cohort of 110 patients with idiopathic CPP was studied. Family history of precocious sexual development was present in 25%. Mutations in the coding region of MKRN3 were excluded in all patients. Genomic DNA was extracted from peripheral blood leukocytes, and 1,100 nucleotides (nt) of the 5'-regulatory region of MKRN3 were amplified and sequenced. Luciferase assays were performed in GT1-7 cells transiently transfected with plasmids containing mutated and wild-type MKRN3 promoter. RESULTS: We identified a rare heterozygous 4-nt deletion (c.-150_-147delTCAG; -38 to -41 nt upstream to the transcription start site) in the proximal promoter region of MKRN3 in a girl with CPP. In silico analysis predicted that this deletion would lead to the loss of a binding site for a downstream res-ponsive element antagonist modulator (DREAM), a potential transcription factor for MKRN3 and GNRH1 expression. Luciferase assays demonstrated a significant reduction of MKRN3 promoter activity in transfected cells with a c.-150_- 147delTCAG construct plasmid in both homozygous and heterozygous states when compared with cells transfected with the corresponding wild-type MKRN3 promoter region. CONCLUSION: A rare genetic alteration in the regulatory region of MKRN3 causes CPP.
CONTEXT: Loss-of-function mutations in the coding region of MKRN3, a maternally imprinted gene at chromosome 15q11.2, are a common cause of familial central precocious puberty (CPP). Whether MKRN3 alterations in regulatory regions can cause CPP has not been explored to date. We aimed to investigate potential pathogenic variants in the promoter region of MKRN3 in patients with idiopathic CPP. PATIENTS/ METHODS: A cohort of 110 patients with idiopathic CPP was studied. Family history of precocious sexual development was present in 25%. Mutations in the coding region of MKRN3 were excluded in all patients. Genomic DNA was extracted from peripheral blood leukocytes, and 1,100 nucleotides (nt) of the 5'-regulatory region of MKRN3 were amplified and sequenced. Luciferase assays were performed in GT1-7 cells transiently transfected with plasmids containing mutated and wild-type MKRN3 promoter. RESULTS: We identified a rare heterozygous 4-nt deletion (c.-150_-147delTCAG; -38 to -41 nt upstream to the transcription start site) in the proximal promoter region of MKRN3 in a girl with CPP. In silico analysis predicted that this deletion would lead to the loss of a binding site for a downstream res-ponsive element antagonist modulator (DREAM), a potential transcription factor for MKRN3 and GNRH1expression. Luciferase assays demonstrated a significant reduction of MKRN3 promoter activity in transfected cells with a c.-150_- 147delTCAG construct plasmid in both homozygous and heterozygous states when compared with cells transfected with the corresponding wild-type MKRN3 promoter region. CONCLUSION: A rare genetic alteration in the regulatory region of MKRN3 causes CPP.
Authors: Gilles M Leclerc; Guy J Leclerc; Spencer L Shorte; L Stephen Frawley; Fredric R Boockfor Journal: Gen Comp Endocrinol Date: 2002-10-15 Impact factor: 2.822
Authors: K Cartharius; K Frech; K Grote; B Klocke; M Haltmeier; A Klingenhoff; M Frisch; M Bayerlein; T Werner Journal: Bioinformatics Date: 2005-04-28 Impact factor: 6.937
Authors: T A Gray; L Hernandez; A H Carey; M A Schaldach; M J Smithwick; K Rus; J A Marshall Graves; C L Stewart; R D Nicholls Journal: Genomics Date: 2000-05-15 Impact factor: 5.736
Authors: Violeta Heras; Susana Sangiao-Alvarellos; Maria Manfredi-Lozano; María J Sanchez-Tapia; Francisco Ruiz-Pino; Juan Roa; Maribel Lara-Chica; Rosario Morrugares-Carmona; Nathalie Jouy; Ana P Abreu; Vincent Prevot; Denise Belsham; Maria J Vazquez; Marco A Calzado; Leonor Pinilla; Francisco Gaytan; Ana C Latronico; Ursula B Kaiser; Juan M Castellano; Manuel Tena-Sempere Journal: PLoS Biol Date: 2019-11-07 Impact factor: 9.593
Authors: Vassos Neocleous; Pavlos Fanis; Meropi Toumba; Barbara Gorka; Ioanna Kousiappa; George A Tanteles; Michalis Iasonides; Nicolas C Nicolaides; Yiolanda P Christou; Kyriaki Michailidou; Stella Nicolaou; Savvas S Papacostas; Athanasios Christoforidis; Andreas Kyriakou; Dimitrios Vlachakis; Nicos Skordis; Leonidas A Phylactou Journal: Front Endocrinol (Lausanne) Date: 2021-09-24 Impact factor: 5.555
Authors: Carlos Eduardo Seraphim; Ana Pinheiro Machado Canton; Luciana Montenegro; Maiara Ribeiro Piovesan; Delanie B Macedo; Marina Cunha; Aline Guimaraes; Carolina Oliveira Ramos; Anna Flavia Figueiredo Benedetti; Andrea de Castro Leal; Priscila C Gagliardi; Sonir R Antonini; Mirta Gryngarten; Andrea J Arcari; Ana Paula Abreu; Ursula B Kaiser; Leandro Soriano-Guillén; Arancha Escribano-Muñoz; Raquel Corripio; José I Labarta; Lourdes Travieso-Suárez; Nelmar Valentina Ortiz-Cabrera; Jesús Argente; Berenice B Mendonca; Vinicius N Brito; Ana Claudia Latronico Journal: J Clin Endocrinol Metab Date: 2021-03-25 Impact factor: 5.958